Explore more publications!
Middle East News Center
Got News to Share?

Middle East News Center: Press Releases

Browse our comprehensive archive of press releases by date.
Select a specific day to access all press releases published on Middle East News Center.

October 2025

Mo Tu We Th Fr Sa Su
1 2 3 4 5
6 7 8 9 10 11 12
13 14 15 16 17 18 19
20 21 22 23 24 25 26
27 28 29 30 31

November 2025

Mo Tu We Th Fr Sa Su
1 2
3 4 5 6 7 8 9
10 11 12 13 14 15 16
17 18 19 20 21 22 23
24 25 26 27 28 29 30

December 2025

Mo Tu We Th Fr Sa Su
1 2 3 4 5 6 7
8 9 10 11 12 13 14
15 16 17 18 19 20 21
22 23 24 25 26 27 28
29 30 31

Press releases published on December 19, 2025

Corporation de minéraux stratégiques du Maroc clôture un placement privé de 600 000$
December 19, 2025

Corporation de minéraux stratégiques du Maroc clôture un placement privé de 600 000$

Indeterminate GlobeNewswire
New Crypto Mutuum Finance (MUTM) Advances Roadmap Execution With Phase 7 Now Underway
December 19, 2025

New Crypto Mutuum Finance (MUTM) Advances Roadmap Execution With Phase 7 Now Underway

Indeterminate GlobeNewswire
Mutuum Finance (MUTM) Reports $19.4M Raised with Over 18.5K Investors Ahead of Q4 2025 V1
December 19, 2025

Mutuum Finance (MUTM) Reports $19.4M Raised with Over 18.5K Investors Ahead of Q4 2025 V1

Indeterminate GlobeNewswire
Polyrizon Submits Pre-Request for Designation to FDA for PL-16 Viral Blocker Designed to Reduce the Exposure to Influenza and Cold Viruses
December 19, 2025

Polyrizon Submits Pre-Request for Designation to FDA for PL-16 Viral Blocker Designed to Reduce the Exposure to Influenza and Cold Viruses

Indeterminate GlobeNewswire
Outlook Therapeutics Reports Financial Results for Fiscal Year 2025
December 19, 2025

Outlook Therapeutics Reports Financial Results for Fiscal Year 2025

Indeterminate GlobeNewswire
Spero Announces NDA Resubmission of Tebipenem HBr by GSK to the FDA for the Treatment of Complicated Urinary Tract Infections, Including Pyelonephritis
December 19, 2025

Spero Announces NDA Resubmission of Tebipenem HBr by GSK to the FDA for the Treatment of Complicated Urinary Tract Infections, Including Pyelonephritis

Indeterminate GlobeNewswire
Cue Biopharma Announces Pricing of $10 Million Public Offering
December 19, 2025

Cue Biopharma Announces Pricing of $10 Million Public Offering

Indeterminate GlobeNewswire
DeFi Crypto Mutuum Finance (MUTM) Confirms Ongoing Halborn Security Review Ahead of Phase 7
December 19, 2025

DeFi Crypto Mutuum Finance (MUTM) Confirms Ongoing Halborn Security Review Ahead of Phase 7

Indeterminate GlobeNewswire
Avicanna Applauds President Trump’s Executive Order to Reclassify Cannabis & Provides Scientific Update
December 19, 2025

Avicanna Applauds President Trump’s Executive Order to Reclassify Cannabis & Provides Scientific Update

Indeterminate GlobeNewswire
OKYO Pharma to Ring the Opening Bell at Nasdaq
December 19, 2025

OKYO Pharma to Ring the Opening Bell at Nasdaq

Indeterminate GlobeNewswire
Altimmune Announces that Pemvidutide Achieved Key Measures of Success at 48 Weeks in IMPACT Phase 2b MASH Trial
December 19, 2025

Altimmune Announces that Pemvidutide Achieved Key Measures of Success at 48 Weeks in IMPACT Phase 2b MASH Trial

Indeterminate GlobeNewswire
Alvotech and Teva Secure U.S. Settlement Date for AVT06, a Proposed Biosimilar to Eylea®
December 19, 2025

Alvotech and Teva Secure U.S. Settlement Date for AVT06, a Proposed Biosimilar to Eylea®

Indeterminate GlobeNewswire
Genenta Science Provides Update on CEO Ownership
December 19, 2025

Genenta Science Provides Update on CEO Ownership

Indeterminate GlobeNewswire

Share us

on your social networks:
Facebook Facebook LinkedIn LinkedIn
AGPs

Get the latest news on this topic.

SIGN UP FOR FREE TODAY

No Thanks

By signing to this email alert, you
agree to our Terms & Conditions